181 related articles for article (PubMed ID: 22441502)
1. Are we being overly cautious? A qualitative inquiry into the experiences and perceptions of treatment-focused germline BRCA genetic testing amongst women recently diagnosed with breast cancer.
Zilliacus E; Meiser B; Gleeson M; Watts K; Tucker K; Lobb EA; Mitchell G
Support Care Cancer; 2012 Nov; 20(11):2949-58. PubMed ID: 22441502
[TBL] [Abstract][Full Text] [Related]
2. How should we discuss genetic testing with women newly diagnosed with breast cancer? Design and implementation of a randomized controlled trial of two models of delivering education about treatment-focused genetic testing to younger women newly diagnosed with breast cancer.
Watts KJ; Meiser B; Mitchell G; Kirk J; Saunders C; Peate M; Duffy J; Kelly PJ; Gleeson M; Barlow-Stewart K; Rahman B; Friedlander M; Tucker K;
BMC Cancer; 2012 Jul; 12():320. PubMed ID: 22838957
[TBL] [Abstract][Full Text] [Related]
3. There is no decision to make: experiences and attitudes toward treatment-focused genetic testing among women diagnosed with ovarian cancer.
Meiser B; Gleeson M; Kasparian N; Barlow-Stewart K; Ryan M; Watts K; Menon D; Mitchell G; Tucker K
Gynecol Oncol; 2012 Jan; 124(1):153-7. PubMed ID: 22032838
[TBL] [Abstract][Full Text] [Related]
4. Psychological outcomes and surgical decisions after genetic testing in women newly diagnosed with breast cancer with and without a family history.
Meiser B; Quinn VF; Mitchell G; Tucker K; Watts KJ; Rahman B; Peate M; Saunders C; Geelhoed E; Gleeson M; Barlow-Stewart K; Field M; Harris M; Antill YC; Susman R; Bowen MT; Mills L; Kirk J;
Eur J Hum Genet; 2018 Jul; 26(7):972-983. PubMed ID: 29599518
[TBL] [Abstract][Full Text] [Related]
5. Getting to the point: what women newly diagnosed with breast cancer want to know about treatment-focused genetic testing.
Meiser B; Gleeson M; Watts K; Peate M; Zilliacus E; Barlow-Stewart K; Saunders C; Mitchell G; Kirk J
Oncol Nurs Forum; 2012 Mar; 39(2):E101-11. PubMed ID: 22374498
[TBL] [Abstract][Full Text] [Related]
6. Streamlined genetic education is effective in preparing women newly diagnosed with breast cancer for decision making about treatment-focused genetic testing: a randomized controlled noninferiority trial.
Quinn VF; Meiser B; Kirk J; Tucker KM; Watts KJ; Rahman B; Peate M; Saunders C; Geelhoed E; Gleeson M; Barlow-Stewart K; Field M; Harris M; Antill YC; Cicciarelli L; Crowe K; Bowen MT; Mitchell G
Genet Med; 2017 Apr; 19(4):448-456. PubMed ID: 27684037
[TBL] [Abstract][Full Text] [Related]
7. When knowledge of a heritable gene mutation comes out of the blue: treatment-focused genetic testing in women newly diagnosed with breast cancer.
Meiser B; Quinn VF; Gleeson M; Kirk J; Tucker KM; Rahman B; Saunders C; Watts KJ; Peate M; Geelhoed E; Barlow-Stewart K; Field M; Harris M; Antill YC; Mitchell G
Eur J Hum Genet; 2016 Nov; 24(11):1517-1523. PubMed ID: 27329735
[TBL] [Abstract][Full Text] [Related]
8. Moving into the mainstream: healthcare professionals' views of implementing treatment focussed genetic testing in breast cancer care.
Hallowell N; Wright S; Stirling D; Gourley C; Young O; Porteous M
Fam Cancer; 2019 Jul; 18(3):293-301. PubMed ID: 30689103
[TBL] [Abstract][Full Text] [Related]
9. Health professionals' evaluation of delivering treatment-focused genetic testing to women newly diagnosed with breast cancer.
Douma KF; Meiser B; Kirk J; Mitchell G; Saunders C; Rahman B; Sousa MS; Barlow-Stewart K; Gleeson M; Tucker K
Fam Cancer; 2015 Jun; 14(2):265-72. PubMed ID: 25391616
[TBL] [Abstract][Full Text] [Related]
10. Communication and information needs of women diagnosed with ovarian cancer regarding treatment-focused genetic testing.
Gleeson M; Meiser B; Barlow-Stewart K; Trainer AH; Tucker K; Watts KJ; Friedlander M; Kasparian N
Oncol Nurs Forum; 2013 May; 40(3):275-83. PubMed ID: 23619104
[TBL] [Abstract][Full Text] [Related]
11. A population-based study of Ashkenazi Jewish women's attitudes toward genetic discrimination and BRCA1/2 testing.
Lehmann LS; Weeks JC; Klar N; Garber JE
Genet Med; 2002; 4(5):346-52. PubMed ID: 12394347
[TBL] [Abstract][Full Text] [Related]
12. Too much, too soon? Patients and health professionals' views concerning the impact of genetic testing at the time of breast cancer diagnosis in women under the age of 40.
Ardern-Jones A; Kenen R; Eeles R
Eur J Cancer Care (Engl); 2005 Jul; 14(3):272-81. PubMed ID: 15952973
[TBL] [Abstract][Full Text] [Related]
13. Oncology health professionals' attitudes toward treatment-focused genetic testing for women newly diagnosed with breast cancer.
Burcher S; Meiser B; Mitchell G; Saunders C; Rahman B; Tucker K; Barlow-Stewart K; Watts K; Gleeson M; Kirk J
Per Med; 2013 Jul; 10(5):431-440. PubMed ID: 29758836
[TBL] [Abstract][Full Text] [Related]
14. Attitudes to reproductive genetic testing in women who had a positive BRCA test before having children: a qualitative analysis.
Ormondroyd E; Donnelly L; Moynihan C; Savona C; Bancroft E; Evans DG; Eeles R; Lavery S; Watson M
Eur J Hum Genet; 2012 Jan; 20(1):4-10. PubMed ID: 21811309
[TBL] [Abstract][Full Text] [Related]
15. Maximising survival: the main concern of women with hereditary breast and ovarian cancer who undergo genetic testing for BRCA1/2.
Jeffers L; Morrison PJ; McCaughan E; Fitzsimons D
Eur J Oncol Nurs; 2014 Aug; 18(4):411-8. PubMed ID: 24731853
[TBL] [Abstract][Full Text] [Related]
16. Patients' Views of Treatment-Focused Genetic Testing (TFGT): Some Lessons for the Mainstreaming of BRCA1 and BRCA2 Testing.
Wright S; Porteous M; Stirling D; Lawton J; Young O; Gourley C; Hallowell N
J Genet Couns; 2018 May; 27(6):1459-72. PubMed ID: 29752676
[TBL] [Abstract][Full Text] [Related]
17. Decision-making on preimplantation genetic diagnosis and prenatal diagnosis: a challenge for couples with hereditary breast and ovarian cancer.
Derks-Smeets IA; Gietel-Habets JJ; Tibben A; Tjan-Heijnen VC; Meijer-Hoogeveen M; Geraedts JP; van Golde R; Gomez-Garcia E; van den Bogaart E; van Hooijdonk M; de Die-Smulders CE; van Osch LA
Hum Reprod; 2014 May; 29(5):1103-12. PubMed ID: 24603131
[TBL] [Abstract][Full Text] [Related]
18. Negotiating jurisdictional boundaries in response to new genetic possibilities in breast cancer care: The creation of an 'oncogenetic taskscape'.
Wright S; Porteous M; Stirling D; Young O; Gourley C; Hallowell N
Soc Sci Med; 2019 Mar; 225():26-33. PubMed ID: 30784848
[TBL] [Abstract][Full Text] [Related]
19. Universal BRCA1/BRCA2 Testing for Ovarian Cancer Patients is Welcomed, but with Care: How Women and Staff Contextualize Experiences of Expanded Access.
Shipman H; Flynn S; MacDonald-Smith CF; Brenton J; Crawford R; Tischkowitz M; ; Hulbert-Williams NJ
J Genet Couns; 2017 Dec; 26(6):1280-1291. PubMed ID: 28540621
[TBL] [Abstract][Full Text] [Related]
20. BRCA mutation-negative women from hereditary breast and ovarian cancer families: a qualitative study of the BRCA-negative experience.
Bakos AD; Hutson SP; Loud JT; Peters JA; Giusti RM; Greene MH
Health Expect; 2008 Sep; 11(3):220-31. PubMed ID: 18816319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
